Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in MADRIGAL PHARMACEUTICALS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 23,796 shares of MDGL (MADRIGAL PHARMACEUTICALS INC), worth $12.5M as of 2026-Q1. The position was decreased (-0.2% shares). MDGL represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$12.5M
Current Shares
23,796
Total Value Change
+$5.6M
Total Shares Change
-813
Other major holders of MDGL: BNP PARIBAS FINANCIAL MARKETS, BAKER BROS. ADVISORS LP, RTW INVESTMENTS, LP, VANGUARD GROUP INC
Decreased |
| 23,796 |
-0.2% |
| $12.5M |
| 0.0% |
| $425.85 |
0 |
| 2025-Q4 | Increased | 23,846 | +1.6% | $13.9M | 0.0% | $583.73 | 28 |
| 2025-Q3 | Decreased | 23,476 | -41.0% | $10.8M | 0.0% | $443.10 | 0 |
| 2025-Q2 | Increased | 39,809 | +51.0% | $12M | 0.0% | $300.75 | 39 |
| 2025-Q1 | Decreased | 26,363 | -4.3% | $8.7M | 0.0% | $327.87 | 0 |
| 2024-Q4 | Increased | 27,538 | +23.2% | $8.5M | 0.0% | $311.62 | 33 |
| 2024-Q3 | Decreased | 22,356 | -9.2% | $4.7M | 0.0% | $212.43 | 0 |
| 2024-Q2 | Increased | 24,609 | +72.9% | $6.9M | 0.0% | $280.16 | 41 |